USANA Health Sciences, Inc.

USNA

US90328M1071

Food Processing

Real-time Estimate Cboe BZX Other stock markets 11:34:45 27/06/2024 pm IST			5-day change	1st Jan Change
45.02 ^USD	+0.08%		-0.89%	-15.85%

07/05	DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating	MT
01/05	Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024

USANA Health Sciences, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year 2022

February 09, 2022 at 02:45 am IST

USANA Health Sciences, Inc. provided consolidated earnings guidance for the fiscal year 2022. For the year, the company expects net sales to be in the range of $1.125 billion to $1.225 billion and diluted EPS to be in the range of $5.25 to $6.00.

Latest news about USANA Health Sciences, Inc.

DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating	07/05	MT
Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024	01/05
(USNA) USANA HEALTH SCIENCES Expects Fiscal Year 2024 Revenue Range $850M - $920M	01/05	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 EPS Range $2.40 - $3.00	01/05	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q1 Revenue $227.8M, vs. Street Est of $226.8M	01/05	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q1 EPS $0.86, vs. Street Est of $0.69	01/05	MT
USANA Health Sciences, Inc. Reiterates Consolidated Earnings Guidance for the Fiscal Year 2024	01/05	CI
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.	01/05	CI
USANA Health Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	01/05	CI
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing	12/03	MT
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing	12/03	MT
WeightWatchers shares drop as Oprah Winfrey decides to exit board	29/02	RE
Transcript : USANA Health Sciences, Inc., Q4 2023 Earnings Call, Feb 07, 2024	07/02
USANA Health Sciences Seeks Acquisition Opportunities	07/02	CI
(USNA) USANA HEALTH SCIENCES Forecasts Q1 Revenue Range $850M - $920M	07/02	MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q4 EPS $0.87, vs. Street Est of $0.52	07/02	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 EPS Range $2.40 - $3	07/02	MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 Revenue Range $850M - $920M	07/02	MT
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015.	07/02	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 30, 2023	07/02	CI
USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2024	07/02	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	07/02	CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	07/02	CI
DA Davidson Cuts USANA Health Sciences' Price Target to $53 From $62, Keeps Neutral Rating	25/23/25	MT
Transcript : USANA Health Sciences, Inc., Q3 2023 Earnings Call, Oct 25, 2023	25/23/25

Chart USANA Health Sciences, Inc.

Duration

Period

More charts

Company Profile

USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Companyâs product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.

Sector

Food Processing

Calendar

23/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for USANA Health Sciences, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

44.99 USD

Average target price

55.5 USD

Spread / Average Target

+23.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
USANA HEALTH SCIENCES, INC.	-15.85%	86Cr
ZHEJIANG NHU COMPANY LTD.	+12.97%	826.94Cr
BELLRING BRANDS, INC.	+3.37%	747.39Cr
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-15.13%	523.48Cr
THE SIMPLY GOOD FOODS COMPANY	-9.80%	361.56Cr
BYHEALTH CO., LTD	-19.61%	326.07Cr
XIAMEN KINGDOMWAY GROUP COMPANY	-12.98%	121.63Cr
HERBALIFE LTD.	-31.16%	106.27Cr
JAMIESON WELLNESS INC.	-10.02%	86Cr
SIRIO PHARMA CO., LTD.	-4.54%	86Cr

Special Foods & Wellbeing Products